Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$4.50
-0.17-3.64%
At close: -
$4.47
-0.03-0.67%
After Hours: Mar 28, 4:12 PM EDT
Comments
Loading...
Organogenesis Holdings Analyst Ratings and Price Targets | NASDAQ:ORGO | Benzinga
Organogenesis Holdings Inc has a consensus price target of $5.5 based on the ratings of 4 analysts. The high is $6 issued by Morgan Stanley on March 5, 2025. The low is $5 issued by Lake Street on June 28, 2024. The 3 most-recent analyst ratings were released by Morgan Stanley, Lake Street, and Cantor Fitzgerald on March 5, 2025, June 28, 2024, and March 1, 2024, respectively. With an average price target of $5.33 between Morgan Stanley, Lake Street, and Cantor Fitzgerald, there's an implied 19.31% upside for Organogenesis Holdings Inc from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Morgan Stanley
Lake Street
Cantor Fitzgerald
BTIG
1calculated from analyst ratings
Analyst Ratings for Organogenesis Holdings
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 03/05/2025 | Buy Now | 34.23% | Morgan Stanley | Drew Ranieri45% | $4 → $6 | Maintains | Equal-Weight | Get Alert |
| 06/28/2024 | Buy Now | 11.86% | Lake Street | Brooks O'Neil36% | → $5 | Initiates | → Buy | Get Alert |
| 03/01/2024 | Buy Now | 11.86% | Cantor Fitzgerald | Ross Osborn50% | $5 → $5 | Reiterates | Overweight → Overweight | Get Alert |
| 02/07/2024 | Buy Now | 11.86% | Cantor Fitzgerald | Ross Osborn50% | → $5 | Initiates | → Overweight | Get Alert |
| 12/27/2023 | Buy Now | 34.23% | BTIG | Ryan Zimmerman73% | $4 → $6 | Maintains | Buy | Get Alert |
| 11/14/2023 | Buy Now | -21.7% | Morgan Stanley | Drew Ranieri45% | $3 → $3.5 | Maintains | Equal-Weight | Get Alert |
| 08/11/2023 | Buy Now | -32.89% | Morgan Stanley | Drew Ranieri45% | $5 → $3 | Maintains | Equal-Weight | Get Alert |
| 08/10/2023 | Buy Now | -10.51% | BTIG | Ryan Zimmerman73% | $10 → $4 | Maintains | Buy | Get Alert |
| 06/15/2023 | Buy Now | 11.86% | Morgan Stanley | Drew Ranieri45% | → $5 | Initiates | → Equal-Weight | Get Alert |
| 05/24/2023 | Buy Now | 123.71% | BTIG | Ryan Zimmerman73% | → $10 | Upgrade | Neutral → Buy | Get Alert |
| 11/10/2022 | Buy Now | — | BTIG | Ryan Zimmerman73% | — | Downgrade | Buy → Neutral | Get Alert |
FAQ
What is the target price for Organogenesis Holdings (ORGO) stock?
The latest price target for Organogenesis Holdings (NASDAQ:ORGO) was reported by Morgan Stanley on March 5, 2025. The analyst firm set a price target for $6.00 expecting ORGO to rise to within 12 months (a possible 34.23% upside). 2 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Organogenesis Holdings (ORGO)?
The latest analyst rating for Organogenesis Holdings (NASDAQ:ORGO) was provided by Morgan Stanley, and Organogenesis Holdings maintained their equal-weight rating.
When was the last upgrade for Organogenesis Holdings (ORGO)?
The last upgrade for Organogenesis Holdings Inc happened on May 24, 2023 when BTIG raised their price target to $10. BTIG previously had a neutral for Organogenesis Holdings Inc.
When was the last downgrade for Organogenesis Holdings (ORGO)?
The last downgrade for Organogenesis Holdings Inc happened on November 10, 2022 when BTIG changed their price target from N/A to N/A for Organogenesis Holdings Inc.
When is the next analyst rating going to be posted or updated for Organogenesis Holdings (ORGO)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Organogenesis Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Organogenesis Holdings was filed on March 5, 2025 so you should expect the next rating to be made available sometime around March 5, 2026.
Is the Analyst Rating Organogenesis Holdings (ORGO) correct?
While ratings are subjective and will change, the latest Organogenesis Holdings (ORGO) rating was a maintained with a price target of $4.00 to $6.00. The current price Organogenesis Holdings (ORGO) is trading at is $4.47, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.